Management of infections in immunocompromised cancer patients.
D000328:Adult; D000380:Agranulocytosis / Q000150:complications*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy; D001803:Blood Transfusion; D016026:Bone Marrow Transplantation; D002511:Cephalosporins / Q000627:therapeutic use; D002648:Child; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D006098:Granulocytes / Q000637:transplantation; D006801:Humans; D007239:Infections / Q000188:drug therapy / Q000628:therapy*; D009181:Mycoses / Q000188:drug therapy; D009369:Neoplasms / Q000150:complications* / Q000276:immunology; D009503:Neutropenia / Q000150:complications* / Q000628:therapy; D014777:Virus Diseases / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D002511:Cephalosporins